Main Category: Pregnancy / Obstetrics
Also Included In: Nutrition / Diet;Â Â Blood / Hematology
Article Date: 20 Jun 2013 – 0:00 PDT
email to a friend  printer friendly  opinions Â
!– rate article
Patient / Public:
Healthcare Prof:
Daily supplementation of iron tablets to pregnant women does not provide any benefits in birth weight or improved infant growth compared to twice weekly supplementation, according to a study by international researchers published in this week’s PLOS Medicine.
Furthermore, twice weekly supplementation is linked to improved adherence rates in pregnant women and may also be linked to improved cognitive development in infants aged six months.
These findings are important as anemia – a condition in which the blood does not supply the body with enough oxygen because of low levels of haemoglobin, the iron-containing pigment that enables red blood cells to carry oxygen – is a widespread global health problem, with over 2 billion people thought to be affected, yet the side effects and costs of daily iron supplementation are challenges to treatment.
The researchers, led by Beverley Biggs from the University of Melbourne in Australia, reached these conclusions by conducting a cluster randomised controlled trial, in which pregnant women in a semi-rural region of Viet Nam were randomized to receive daily iron-folic acid supplementation (426 women), twice weekly iron-folic acid supplementation (425 women), or twice weekly iron-folic acid supplementation plus micronutrients (407 women).
The researchers (also the authors of this paper) found that birth weight was similar in all supplement groups, and there were also no differences in rates of prematurity, stillbirth, or early neonatal death. At six months, there were also no differences in the levels of infant hemoglobin, prevalence of anemia, or growth rates.
However, the authors found that infants born to mothers in the twice weekly iron-folic acid supplement group had improved cognitive development compared to infants born to mothers in the daily supplement group. Finally, the authors found that adherence rates were significantly higher in the twice weekly iron-folic acid supplement group compared to the once daily regime.
The authors say: “We have shown that twice weekly antenatal [iron-folic acid supplementation] or [multiple micronutrient supplementation] in an area of Southeast Asia with low anemia prevalence did not produce a clinically important difference in birth weight or infant growth outcomes, compared to daily antenatal [iron-folic acid supplementation].â€
They continue: “Our finding of a significant improvement in infant cognitive outcome at 6 months of age following twice weekly antenatal [iron-folic acid supplementation] requires further exploration, and provides additional support for the use of intermittent over daily antenatal [iron-folic acid supplementation] regimes in populations with low rates of iron deficiency.â€
- Additional
- References
- Citations
Funding: This study was funded through a grant from the National Health and Medical Research Coucil of Australia (Grant number 628751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Citation: Hanieh S, Ha TT, Simpson JA, Casey GJ, Khuong NC, et al. (2013) The Effect of Intermittent Antenatal Iron Supplementation on Maternal and Infant Outcomes in Rural Viet Nam: A Cluster Randomised Trial. PLoS Med 10(6): e1001470. doi:10.1371/journal.pmed.1001470
ACCESS TO THE FREELY AVAILABLE PAPER:
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001470
Public Library of Science
Please use one of the following formats to cite this article in your essay, paper or report:
MLA
APA
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
‘Iron Supplementation During Pregnancy: Twice Weekly As Effective As A Daily Regime’
Please note that we publish your name, but we do not publish your email address. It is only used to let
you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2013
MNT (logo) is the registered trade mark of MediLexicon International Ltd.
back to top | home |
privacy policy
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2013
MNT (logo) is the registered trade mark of MediLexicon Int. Limited.